Curbside Consults

The COVID-19 pandemic has forced innovation in health care in many ways, one of which is putting to test advances in digital health. There has been no better time to test its value than in this environment of social distancing, reduced contact, and heightened health...

In this episode of Curbside Consults: Statistical Review, we explore the interpretation of secondary outcomes in clinical trials using the following two articles recently published in NEJM: Bonaca MP et al. Rivaroxaban in Peripheral Artery Disease after Revascularization...

In today’s podcast we are joined by Dr. Marc Bonaca to discuss the findings of the recent VOYAGER PAD trial and the use of low-dose rivaroxaban in peripheral artery disease after revascularization.

In this episode of Curbside Consults, we continue our exploration of the prescription and use of opioids in the treatment of chronic pain. We hear a patient’s point of view, exploring how a patient with chronic pain manages his relationship with his provider, pharmacy, and...

In this statistical review episode of Curbside Consults, we explore descriptive epidemiology studies of the COVID-19 outbreak using an article by Guan and colleagues published online in NEJM on February 28, 2020. To help explain the approach to outbreak study analysis...

Managing patients with chronic pain is a constant challenge for physicians. We frequently receive questions from clinicians about handling these complex situations. Questions about prescribing opioids include when to use opioids and how to monitor their use. In this...

In this special episode of Curbside Consults, this year’s NEJM Editorial Fellows discuss Quality Improvement (QI) in residency and the launch of the NEJM Resident 360 QI Challenge.

The winter peak in respiratory tract infections adds considerable pressure to pediatric emergency departments and intensive care units across the country. In this episode of Curbside Consults, Dr. Phoebe Yager, pediatric intensivist and Chief of the Division of...

Survival data are central to the analysis of clinical trials, with many journal club discussions anchored around the tables and graphs used to display these outcomes. In this episode of Curbside Consults, we are joined once again by Dr. David Harrington, statistical editor...

In the summer of 2019, the medical community was faced with a mysterious series of acute and severe lung illnesses linked to e-cigarette use. In this episode of Curbside Consults, Dr. John Brownstein, chief innovation officer at Boston Children’s Hospital, discusses how...